CASA: Substance Abuse & Addiction Cost US Taxpayers Billions

BlogArticlesCASA: Substance Abuse & Addiction Cost US Taxp...

Our Therapies Explained

At Sobriety.ca Foundation, we offer several services above our therapeutic addiction treatment programs. Whether you are a friend, family member, coworker, or boss, often it’s hard to know what to do to help. Sobriety.ca Foundation is here to guide you.

Table of Contents

More Articles

Listen to Gary, one of our many success stories, describe his experience with us:

More Success Stories

Sobriety.ca Foundation. We're here to help.

Drug Rehab & Alcohol Addiction Treatment at Sobriety.ca Foundation offers a private, secure, tranquil residential rehab with personalized, individual treatment.

Call 1-888-999-8101

Recently, The National Center on Addiction & Substance Abuse at Columbia University (CASA) released a new report detailing the costs of substance abuse and addiction to local, state, and federal governments in the US. The 287-page report, Shoveling Up II: The Impact of Substance Abuse on Federal, State, and Local Budgets, is the first to calculate costs on all three levels.

According to CASA, in 2005 a total of $467.7 billion US was spent by governments across all three levels, in what was deemed a “reckless misallocation of public funds.”

Of the nearly half-trillion of taxpayer money:

  • 95.6% ($357.4 billion US) was devoted to cleaning up the consequences of substance abuse and addiction–crime, health care costs, child abuse, domestic violence, homelessness, and other problems associated with addiction
  • of this money, 58% was associated to health care costs and 13.1% to justice systems
  • only 1.9% was streamed to prevention and treatment
  • of the rest of the money, 0.4% was spent of research; 1.4% to taxation and regulation; 0.7% to interdiction
  • $238.2 billion was spent by the federal government
  • $135.8 billion by state governments
  • $93.8 billion by local governments

Detailing cost effect solutions for this ill-fated spending, CASA offered remedies in the categories of:

  • prevention and early intervention
  • treatment and disease management
  • tax and regulatory policies
  • expanded research